You can buy or sell Ekso Bionics and other stocks, options, and ETFs commission-free!
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA. The listed name for EKSO is Ekso Bionics Holdings, Inc. Common Stock.
52 Week High
52 Week Low
Recap: Ekso Bionics Holdings Q4 Earnings
Shares of Ekso Bionics Holdings (NASDAQ:EKSO) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreas
-$0.30 per share
-$0.48 per share